ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693765 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693765; 2) Community: the network communities that were significantly associated with the response to NSC 693765; 3) Molecule: the relationships between components within communities and NSC 693765; 4) MDR: the compounds that were significantly associated with the NSC 693765.

NSC Compound Enrichment Correlation
NSC 740605 4-Epi-7-oxo-phomopsolide E 0.0385203205529759 -0.13048951
NSC 755426 Null 0.0385203205529759 -0.075900886
NSC 758357 2-oxo-N-(pyridin-4-yl)-2-(1-tosyl-1H-indol-3-yl)acetamide 0.0385203205529759 -0.066183573
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0396077140933374 0.20917078
NSC 727357 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) 0.0396077140933374 0.11517679
NSC 731928 haterumalide NA methyl esters 0.0396077140933374 0.20471191
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0396077140933377 -0.029156401
NSC 335995 Null 0.0396077140933377 0.034126202
NSC 349622 Cytovaricin 0.0396077140933377 0.039643915
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.0396077140933377 -0.039728812
Total:50  Current:39    [First] [Prev] [Next] [Last]